All In MedTech

FDA Clearance Tracker · K020089

MAHURKAR TRIPLE LUMEN CATHETER, 12 FR

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: Apr 10, 2002 (this decision)Source: openFDAMethods & limitations

510(k)First of its product code

Decided

Apr 10, 2002

Substantially Equivalent

Time to decision

90 days

Received Jan 10, 2002. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K020089
Device name
MAHURKAR TRIPLE LUMEN CATHETER, 12 FR
Applicant location
Mansfield, MA
Received
Jan 10, 2002
Decided
Apr 10, 2002
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 876.5540

Every decision under product code NIE

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code NIE (Catheter, Hemodialysis, Triple Lumen, Non-Implanted).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

  • FDA database record for K020089
  • The applicant filed a summary instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for The Kendall Company

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.